| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $27.2M | -26.4% |
| SG&A Expense | $15.8M | -20.3% |
| Operating Income | -$45.8M | -3.2% |
| Income Tax | $0 | — |
| Net Income | -$43.0M | -19.5% |
| EPS (Basic) | -$21.33 | -1951.0% |
| EPS (Diluted) | -$21.33 | -1951.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.0M | +46.0% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $2.2M | +8.8% |
| Current Assets | $41.1M | -49.4% |
| Total Assets | $46.1M | -48.5% |
| Current Liabilities | $7.1M | -26.6% |
| Total Liabilities | $8.1M | -39.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.4M | +8.6% |
| Capital Expenditures | $398K | -45.3% |
| Investing Cash Flow | $51.7M | +35.0% |
| Financing Cash Flow | $276K | +110.8% |
| Free Cash Flow | -$40.8M | +9.2% |
| Stockholders' Equity |
| $37.9M |
| -50.1% |